RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+19.56%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$940M
AUM Growth
+$940M
(-11%)
Cap. Flow
-$249M
Cap. Flow
% of AUM
-26.46%
Top 10 Holdings %
Top 10 Hldgs %
62.65%
Holding
57
New
1
Increased
–
Reduced
32
Closed
9
Top Buys
| 1 |
HNGE
Hinge Health, Inc.
HNGE
|
$15.5M |
Top Sells
| 1 |
Amicus Therapeutics
FOLD
|
$47.8M |
| 2 |
Scholar Rock
SRRK
|
$16.6M |
| 3 |
Cogent Biosciences
COGT
|
$12.7M |
| 4 |
Boston Scientific
BSX
|
$11.6M |
| 5 |
Krystal Biotech
KRYS
|
$10.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Masimo
MASI
$7.43B
| – | – |
-26,062
| Closed | -$4.34M |
|
52
iRhythm Technologies
IRTC
$5.67B
| – | – |
-56,844
| Closed | -$5.95M |
|
53
Immunovant
IMVT
$2.91B
| – | – |
-490,394
| Closed | -$8.38M |
|
54
Cytokinetics
CYTK
$5.98B
| – | – |
-82,098
| Closed | -$3.3M |
|
55
BioNTech
BNTX
$24.1B
| – | – |
-73,071
| Closed | -$6.65M |
|
56
Astria Therapeutics
ATXS
$394M
| – | – |
-269,078
| Closed | -$1.44M |
|
|
ALLK
57
DELISTED
Allakos
ALLK
| – | – |
-856,615
| Closed | -$195K |
|